PS
IMCR icon

Principal Securities’s Immunocore IMCR Stock Holding History

Principal Securities’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-116
Closed -$4.21K – 2401
2025
Q3 		$4.21K Hold
116
– – ﹤0.01% 3019
2025
Q2 		$3.64K Buy
116
+20
+21% +$621 ﹤0.01% 2961
2025
Q1 		$2.83K Hold
96
– – ﹤0.01% 2947
2024
Q4 		$2.83K Buy
96
+24
+33% +$759 ﹤0.01% 2942
2024
Q3 		$2.24K Sell
72
-9
-11% -$327 ﹤0.01% 2921
2024
Q2 		$2.75K Buy
81
+12
+17% +$612 ﹤0.01% 2816
2024
Q1 		$4.49K Sell
69
-40
-37% -$2.75K ﹤0.01% 2643
2023
Q4 		$7.45K Buy
+109
New +$5.67K ﹤0.01% 2385

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Principal Securities's IMCR Position: Q4 2025 in Review

Principal Securities sold out of Immunocore (IMCR) in Q4 2025, closing a stake of 116 shares — an estimated $4.21K sold.

Principal Securities first reported a position in IMCR in Q4 2023 and held it in 8 quarters. The position peaked at $7.45K in Q4 2023. 149 funds tracked by Wall St. Rank hold IMCR as of Q4 2025.

  • Principal Securities reported no remaining Immunocore position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 116 Immunocore shares in Q4 2025, an estimated $4.21K.
  • Principal Securities first reported a position in Immunocore in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Immunocore position peaked at $7.45K in Q4 2023.
  • 149 funds tracked by Wall St. Rank held Immunocore as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.